Stephen Stahl
#21,438
Most Influential Person Now
American psychiatrist
Stephen Stahl's AcademicInfluence.com Rankings
Download Badge
Biology
Why Is Stephen Stahl Influential?
(Suggest an Edit or Addition)According to Wikipedia, Stephen Michael Stahl is an author and professor of psychiatry with expertise in psychopharmacology. He is currently a professor at the University of California, San Diego, and serves as Honorary Fellow in psychiatry department at the University of Cambridge. He is also the chairman of Neuroscience Education Institute and Arbor Scientia Group.
Stephen Stahl's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The dopamine hypothesis of schizophrenia: a review. (1976) (840)
- Essential Psychopharmacology: Neuroscientific Basis and Practical Applications (1996) (648)
- A novel augmentation strategy for treating resistant major depression. (2001) (497)
- Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. (1998) (476)
- SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants (2005) (439)
- A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor. (2004) (417)
- The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. (1977) (393)
- Stahl's essential psychopharmacology : neuroscientific basis and practical application (2008) (393)
- Cholinesterase inhibitors for Alzheimer's disease. (1998) (383)
- Effectiveness of St John's wort in major depression: a randomized controlled trial. (2001) (370)
- Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action. (1998) (297)
- Which comes first: atypical antipsychotic treatment or cardiometabolic risk? (2009) (258)
- The many faces of fatigue in major depressive disorder. (2005) (253)
- 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL. (2005) (237)
- Modelling dementia: Effects of scopolamine on memory and attention (1988) (223)
- Hyperserotonemia and amine metabolites in autistic and retarded children. (1977) (209)
- Rationale, pharmacology and clinical efficacy of partial agonists of α4β2 nACh receptors for smoking cessation (2007) (202)
- Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. (2003) (199)
- Negative symptoms of schizophrenia: a problem that will not go away (2007) (189)
- Mechanism of Action of Trazodone: a Multifunctional Drug (2009) (184)
- A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation. (2004) (179)
- Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or Cul‐de‐sac? (2007) (177)
- Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration. (1988) (170)
- Mirtazapine: An Antidepressant with Noradrenergic and Specific Serotonergic Effects (1997) (170)
- A kinetic and pharmacologic analysis of 5-hydroxytryptamine transport by human platelets and platelet storage granules: comparison with central serotonergic neurons. (1978) (167)
- Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial. (2003) (162)
- Glutamate Neurocircuitry: Theoretical Underpinnings in Schizophrenia (2012) (153)
- Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review (2017) (147)
- The psychopharmacology of energy and fatigue. (2002) (144)
- Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline (2000) (143)
- Hyperserotonemia and platelet serotonin uptake and release in schizophrenia and affective disorders. (1983) (141)
- Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression (2002) (141)
- The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice. (2003) (140)
- Monoamine Oxidase Inhibitors: A Modern Guide to an Unrequited Class of Antidepressants (2008) (139)
- Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action. (2001) (139)
- Antipsychotic polypharmacy, Part 1: Therapeutic option or dirty little secret? (1999) (139)
- Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics (2010) (139)
- Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. (2021) (137)
- Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 1, "Goldilocks" actions at dopamine receptors. (2001) (136)
- The metabolic syndrome and schizophrenia (2009) (133)
- Peptides and psychiatry, Part 1: How synthesis of neuropeptides differs from classical neurotransmitter synthesis. (1999) (130)
- Comprar Stahl's Essential Psychopharmacology. Neuroscientific Basis and Practical Applications | Stephen M. Stahl | 9780521857024 | Cambridge University Press (2008) (130)
- Understanding pain in depression (2004) (127)
- How psychiatrists can build new therapies for impotence. (1998) (127)
- Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials. (1999) (127)
- Stahl's essential psychopharmacology : the prescriber's guide (2014) (126)
- Is psychopharmacologic "inoculation" effective in preventing posttraumatic stress disorder? (2005) (123)
- Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder. (2011) (123)
- Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation. (2007) (122)
- A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature (2015) (122)
- 13 – Platelets as Pharmacologic Models for the Receptors and Biochemistry of Monoaminergic Neurons (1985) (122)
- Computed tomographic evidence for generalized sulcal and ventricular enlargement in schizophrenia. (1988) (117)
- A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression. (1997) (117)
- Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (2010) (112)
- Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate (2018) (111)
- 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs? (1994) (110)
- Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders. (2000) (109)
- Does depression hurt? (2002) (107)
- Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from a randomized clinical trial. (2014) (107)
- Agomelatine in the treatment of major depressive disorder: an 8-week, multicenter, randomized, placebo-controlled trial. (2010) (104)
- Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies. (2008) (100)
- Risperidone and paroxetine given singly and in combination for bipolar depression. (2004) (100)
- The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities? (2013) (99)
- Serotonergic drugs for depression and beyond. (2013) (95)
- Guidelines for the recognition and management of mixed depression. (2017) (93)
- Building a better antipsychotic: Receptor targets for the treatment of multiple symptom dimensions of schizophrenia (2011) (90)
- Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder (2015) (90)
- Dosing Atypical Antipsychotics (2008) (89)
- Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline. (2001) (89)
- Stimulation of the β3-Adrenoceptor as a Novel Treatment Strategy for Anxiety and Depressive Disorders (2008) (88)
- Atypical Antipsychotics: Matching Receptor Profile to Individual Patient's Clinical Profile (2004) (87)
- Stahl's Essential Psychopharmacology (2022) (86)
- Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder. (2002) (84)
- Psychopharmacology of Antidepressants (1997) (84)
- Effects of a Tryptophan-Free Amino Acid Drink Challenge on Normal Human Sleep Electroencephalogram and Mood (1998) (84)
- Safety profile of sustained-release bupropion in depression: results of three clinical trials. (1999) (83)
- The relevance of COVID‐19 pandemic to psychiatry (2020) (83)
- Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects. (2013) (82)
- Beyond the Dopamine Hypothesis to the NMDA Glutamate Receptor Hypofunction Hypothesis of Schizophrenia (2007) (82)
- The clinical and pathological spectrum of brain-stem vascular malformations. Long-term course stimulates multiple sclerosis. (1980) (80)
- A proposal for an updated neuropsychopharmacological nomenclature (2014) (80)
- Continuous cataplexy in a patient with a midbrain tumor (1980) (79)
- Antipsychotic polypharmacy: evidence based or eminence based? (2002) (78)
- Describing an Atypical Antipsychotic: Receptor Binding and Its Role in Pathophysiology (2003) (77)
- Basic psychopharmacology of antidepressants, part 2: Estrogen as an adjunct to antidepressant treatment. (1998) (72)
- Selective Histamine H1 Antagonism: Novel Hypnotic and Pharmacologic Actions Challenge Classical Notions of Antihistamines (2008) (72)
- The pharmacodynamic effects of combined administration of flibanserin and alcohol (2017) (70)
- Long-acting injectable antipsychotics: shall the last be first? (2014) (68)
- Major Depressive Disorder: Understanding the Significance of Residual Symptoms and Balancing Efficacy with Tolerability. (2015) (67)
- Novel Therapeutics for Depression: L-methylfolate as a Trimonoamine Modulator and Antidepressant-Augmenting Agent (2007) (66)
- Antipsychotic polypharmacy: squandering precious resources? (2002) (66)
- Drug research: A plan for mental illness (2012) (66)
- Evidence of early onset of antidepressant effect in randomized controlled trials. (2001) (65)
- A Double-Blind, Placebo-Controlled Trial of Clonazepam in Obsessive-Compulsive Disorder (2003) (65)
- Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats (1988) (64)
- The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies. (2012) (64)
- Peripheral models for the study of neurotransmitter receptors in man. (1985) (62)
- The psychopharmacology of painful physical symptoms in depression. (2002) (62)
- Akathisia and tardive dyskinesia. Changing concepts. (1985) (62)
- L-methylfolate: a vitamin for your monoamines. (2008) (60)
- Not so selective serotonin reuptake inhibitors. (1998) (60)
- Mechanism of action of cariprazine (2016) (59)
- Mechanism of action of brexpiprazole: comparison with aripiprazole (2016) (59)
- High-cost use of second-generation antipsychotics under California's Medicaid program. (2006) (59)
- Platelet alpha2-adrenergic receptor sensitivity in major depressive disorder (1983) (58)
- Neuroscientific basis and practical applications (2008) (58)
- Effectiveness of lurasidone for patients with schizophrenia following 6 weeks of acute treatment with lurasidone, olanzapine, or placebo: a 6-month, open-label, extension study. (2013) (57)
- “Meta-guidelines” for the management of patients with schizophrenia (2013) (57)
- Opportunities for reversible inhibitors of monoamine oxidase-A (RIMAs) in the treatment of depression (2012) (56)
- Psychotherapy as an epigenetic ‘drug’: psychiatric therapeutics target symptoms linked to malfunctioning brain circuits with psychotherapy as well as with drugs (2012) (55)
- Antidepressant Treatment of Psychotic Major Depression: Potential Role of the σ Receptor (2005) (54)
- Differences in mechanism of action between current and future antidepressants. (2003) (53)
- Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms. (1996) (52)
- The Mechanism of Drug-induced Akathisia (2011) (52)
- Emotion processing, the amygdala, and outcome in schizophrenia (2005) (51)
- Why settle for silver, when you can go for gold? Response vs. recovery as the goal of antidepressant therapy. (1999) (50)
- Essential Psychopharmacology of Depression and Bipolar Disorder (2000) (50)
- Vilazodone: a brief pharmacological and clinical review of the novel serotonin partial agonist and reuptake inhibitor (2011) (50)
- Fibromyalgia—pathways and neurotransmitters (2009) (49)
- Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels. (2004) (49)
- Psychopharmacology of Antipsychotics (1999) (49)
- Future directions in anxiolytic pharmacotherapy. (1995) (47)
- Neuropharmacology of obesity: my receptors made me eat it. (1998) (46)
- The new cholinesterase inhibitors for Alzheimer's disease, Part 2: illustrating their mechanisms of action. (2000) (46)
- Mechanism of action of alpha2delta ligands: voltage sensitive calcium channel (VSCC) modulators. (2004) (46)
- Genetic data supporting the NMDA glutamate receptor hypothesis for schizophrenia. (2012) (46)
- Cerebral metabolism of Parkinsonian primates 21 days after MPTP (1988) (45)
- Practical guide for prescribing MAOIs: debunking myths and removing barriers (2012) (45)
- Bromocriptine, physostigmine, and neurotransmitter mechanisms in the dystonias (1982) (45)
- Tailoring Treatment of Depression for Women Across the Reproductive Lifecycle: The Importance of Pregnancy, Vasomotor Symptoms, and Other Estrogen-Related Events in Psychopharmacology (2008) (45)
- Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes (2017) (44)
- Efficacy of ziprasidone in dysphoric mania: Pooled analysis of two double-blind studies (2007) (43)
- Essential psychopharmacology of antipsychotics and mood stabilizers (2002) (42)
- Neurotransmission of cognition, part 1, Dopamine is a hitchhiker in frontal cortex: norepinephrine transporters regulate dopamine. (2003) (42)
- Multifunctional Drugs: A Novel Concept for Psychopharmacology (2009) (42)
- Depression and bipolar disorder (2008) (41)
- Mixed anxiety and depression: clinical implications. (1993) (41)
- Gamma-vinyl-GABA treatment of tardive dyskinesia and other movement disorders (1985) (41)
- Enhancing Outcomes from Major Depression: Using Antidepressant Combination Therapies with Multifunctional Pharmacologic Mechanisms from the Initiation of Treatment (2010) (41)
- A randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuria. (2015) (41)
- Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): enhancing serotonin release by combining serotonin (5HT) transporter inhibition with actions at 5HT receptors (5HT1A, 5HT1B, 5HT1D, 5HT7 receptors) (2015) (40)
- The sigma enigma: can sigma receptors provide a novel target for disorders of mood and cognition? (2008) (40)
- Mechanism of action of pimavanserin in Parkinson’s disease psychosis: targeting serotonin 5HT2A and 5HT2C receptors (2016) (40)
- Modulating the serotonin system in the treatment of major depressive disorder (2014) (39)
- The 5-HT1A agonist ipsapirone enhances EEG slow wave activity in human sleep and produces a power spectrum similar to 5-HT2 blockade (1996) (39)
- Neurotransmission of cognition, part 2. Selective NRIs are smart drugs: exploiting regionally selective actions on both dopamine and norepinephrine to enhance cognition. (2003) (39)
- Examination of nighttime sleep-related problems during double-blind, placebo-controlled trials of galantamine in patients with Alzheimer's disease (2004) (39)
- Anticonvulsants as anxiolytics, part 2: Pregabalin and gabapentin as alpha(2)delta ligands at voltage-gated calcium channels. (2004) (39)
- Treatment Strategies for Dosing the Second Generation Antipsychotics (2011) (38)
- Blue genes and the monoamine hypothesis of depression. (2000) (38)
- Platelet serotonin in schizophrenia and depression. (1982) (38)
- Co-use of donepezil and hypnotics among Alzheimer's disease patients living in the community. (2003) (38)
- Mixed depression and anxiety: serotonin1A receptors as a common pharmacologic link. (1997) (38)
- Anticonvulsants and the relief of chronic pain: pregabalin and gabapentin as alpha(2)delta ligands at voltage-gated calcium channels. (2004) (37)
- 18Fluorodeoxyglucose PET in schizophrenia (1985) (37)
- Effects of lorazepam on memory, attention and sedation in man (2004) (37)
- Focus on antipsychotic polypharmacy: evidence-based prescribing or prescribing-based evidence? (2004) (37)
- The pharmacology of depression: studies of neurotransmitter receptors lead the search for biochemical lesions and new drug therapies (1986) (36)
- TRPV1 Antagonists and Chronic Pain: Beyond Thermal Perception (2012) (36)
- Antipsychotic polypharmacy, part 2: tips on use and misuse. (1999) (36)
- The Neuropharmacology of Tardive Dyskinesia, Spontaneous Dyskinesia, and Other Dystonias (1982) (36)
- Antipsychotic polypharmacy: never say never, but never say always (2012) (35)
- Novel mechanism of antidepressant action: norepinephrine and dopamine disinhibition (NDDI) plus melatonergic agonism. (2007) (35)
- The psychopharmacology of sex, Part 1: Neurotransmitters and the 3 phases of the human sexual response. (2001) (35)
- Temperature Regulation in Depression: Functional 5HT1A Receptor Adaptation Differentiates Antidepressant Response (2006) (35)
- The human platelet as a model for the dopaminergic neuron: Kinetic and pharmacologic properties and the role of amine storage granules (1978) (35)
- Antiparkinsonian efficacy of a novel transdermal delivery system for (+)-PHNO in MPTP-treated squirrel monkeys (1989) (34)
- Emerging guidelines for the use of antipsychotic polypharmacy. (2013) (34)
- Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorder* (2007) (34)
- Iloperidone, asenapine and lurasidone: a primer on their current status (2012) (34)
- Parkinson’s disease psychosis as a serotonin-dopamine imbalance syndrome (2016) (34)
- A pharmacologic study of the stiff‐man syndrome (1975) (33)
- Serotonin and schizophrenia: Correlations between serotonergic activity and schizophrenic motor behavior (1985) (33)
- Attention-Deficit and Disruptive Behavior Disorders (2014) (33)
- Antidepressants and somatic symptoms: therapeutic actions are expanding beyond affective spectrum disorders to functional somatic syndromes. (2003) (33)
- Mechanism of action of agomelatine: a novel antidepressant exploiting synergy between monoaminergic and melatonergic properties (2014) (33)
- Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy (2014) (32)
- Augmentation of antidepressants by estrogen. (1998) (32)
- Effects of Reboxetine on Anxiety, Agitation, and Insomnia: Results of a Pooled Evaluation of Randomized Clinical Trials (2002) (32)
- Ipsapirone, a 5-HT1A Agonist, Suppresses REM Sleep Equally in Unmedicated Depressed Patients and Normal Controls (1996) (32)
- Galactorrhea induced by sertraline. (1993) (32)
- The sigma-1 (delta-1) receptor and its role in the treament of mood disorders (2009) (31)
- The Potential Role of a Corticotropin-Releasing Factor Receptor-1 Antagonist in Psychiatric Disorders (2008) (31)
- Independent regulation of β1‐ and β2‐adrenoceptors (1987) (31)
- Basal ganglia neuropharmacology and obsessive-compulsive disorder: the obsessive-compulsive disorder hypothesis of basal ganglia dysfunction. (1988) (31)
- Deconstructing violence as a medical syndrome: mapping psychotic, impulsive, and predatory subtypes to malfunctioning brain circuits (2014) (30)
- "Hit-and-run" actions at dopamine receptors, part 1: Mechanism of action of atypical antipsychotics. (2001) (30)
- Inhibition of REM sleep by ipsapirone, A 5HT1A agonist, in normal volunteers (1994) (30)
- Cariprazine as a treatment across the bipolar I spectrum from depression to mania: mechanism of action and review of clinical data (2020) (30)
- Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders. (2008) (30)
- Symptoms and circuits, part 3: schizophrenia. (2004) (29)
- Effects of lorazepam on memory, attention and sedation in man: antagonism by Ro 15-1788 (2004) (29)
- Are two antidepressant mechanisms better than one? (1997) (29)
- California State Hospital Violence Assessment and Treatment (Cal-VAT) guidelines (2014) (29)
- Targeting circuits of sexual desire as a treatment strategy for hypoactive sexual desire disorder. (2010) (29)
- Cortisol and growth hormone responses to the 5-HT1A agonist gepirone in depressed patients (1990) (29)
- Brainstorms: Mechanism of Action of α 2 δ Ligands: Voltage Sensitive Calcium Channel (VSCC) Modulators (2004) (28)
- Development of new antidepressants. (1997) (28)
- Toward convergence in the medication treatment of bipolar disorder and schizophrenia. (2005) (28)
- Human sleep EEG following the 5-HT1A antagonist pindolol: possible disinhibition of raphe neuron activity (1997) (28)
- In vitro selectivity of agonists and antagonists for beta 1- and beta 2-adrenoceptor subtypes in rat brain. (1988) (28)
- The serotonin-7 receptor as a novel therapeutic target. (2010) (28)
- INJECTION OF 6‐HYDROXYDOPAMINE AND HYDROGEN PEROXIDE INTO THE SUBSTANTIA NIGRA AND LATERAL VENTRICLE OF THE CAT: SPECIFIC AND NONSPECIFIC EFFECTS ON STRIATAL BIOGENIC AMINES 1 (1975) (27)
- Meta-analysis of randomized, double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression. (1997) (27)
- Symptoms and Circuits, Part 2 Anxiety Disorders (2003) (27)
- Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients. (1974) (27)
- Using secondary binding properties to select a not so selective serotonin reuptake inhibitor. (1998) (27)
- Antipsychotic drug development. (2010) (27)
- Does treating hearing loss prevent or slow the progress of dementia? Hearing is not all in the ears, but who’s listening? (2017) (27)
- Prolonged neuropsychiatric effects following management of chloroquine intoxication with psychotropic polypharmacy (2015) (27)
- Methylated Spirits: Epigenetic Hypotheses of Psychiatric Disorders (2010) (26)
- Effectiveness of ipsapirone, a 5-HT-1A partial agonist, in major depressive disorder: support for the role of 5-HT-1A receptors in the mechanism of action of serotonergic antidepressants. (1998) (26)
- Tardive Tourette syndrome in an autistic patient after long-term neuroleptic administration. (1980) (26)
- REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial. (2021) (26)
- The last Diagnostic and Statistical Manual (DSM): replacing our symptom-based diagnoses with a brain circuit-based classification of mental illnesses (2013) (26)
- Meta‐analysis of randomized, double‐blind, dacebo‐controlled, efficacy and safety studies of mirtazapine versus amitripcyline in major depression (1997) (26)
- Does evidence from clinical trials in psychopharmacology apply in clinical practice? (2001) (26)
- CSF Monoamine Metabolites in Movement Disorders and Normal Aging (1985) (25)
- Case report of tardive dyskinesia and parkinsonism associated with amoxapine therapy. (1984) (25)
- Effects of estrogen on the central nervous system. (2001) (25)
- Long-term motor stimulant effects of (+)-4-propyl-9-hydroxynaphthoxazine (PHNO), a dopamine D-2 receptor agonist: interactions with a dopamine D-1 receptor antagonist and agonist. (1988) (25)
- A Post Hoc Analysis of Negative Symptoms and Psychosocial Function in Patients With Schizophrenia: A 40-Week Randomized, Double-Blind Study of Ziprasidone Versus Haloperidol Followed by a 3-Year Double-Blind Extension Trial (2010) (25)
- Anticonvulsants as anxiolytics, part 1: tiagabine and other anticonvulsants with actions on GABA. (2004) (24)
- Stahl's essential psychopharmacology: Prescriber's guide, 5th ed. (2014) (24)
- Antiparkinsonian activity of (+)‐PHNO in the MPTP‐treated common marmoset (1987) (24)
- An ideal trial to test differential onset of antidepressant effect. (2001) (23)
- Psychopharmacology of Persistent Violence and Aggression. (2016) (23)
- The psychopharmacology of sex, part 2: effects of drugs and disease on the 3 phases of human sexual response. (2001) (23)
- Nitric oxide physiology and pharmacology. (1998) (23)
- Neuroendocrine markers of serotonin responsivity in depression (1992) (23)
- Pilot study on the effects of fenfluramine on negative symptoms in twelve schizophrenic inpatients (1985) (23)
- Mechanism of action of the SPARI vilazodone: serotonin 1A partial agonist and reuptake inhibitor (2014) (23)
- Psychopharmacology of anticonvulsants: levetiracetam as a synaptic vesicle protein modulator. (2004) (23)
- Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): blocking 5HT3 receptors enhances release of serotonin, norepinephrine, and acetylcholine (2015) (22)
- The new cholinesterase inhibitors for Alzheimer's disease, Part 1: their similarities are different. (2000) (22)
- Progressive myelopathy due to extramedullary hematopoiesis: Case report and review of the literature (1979) (22)
- How to appease the appetite of psychotropic drugs. (1998) (22)
- Awakening to the psychopharmacology of sleep and arousal: novel neurotransmitters and wake-promoting drugs. (2002) (22)
- Dextromethorphan/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal Activity (2019) (22)
- The prefrontal cortex is out of tune in attention-deficit/hyperactivity disorder. (2009) (22)
- Circuits of sexual desire in hypoactive sexual desire disorder. (2010) (22)
- Role of α1 adrenergic antagonism in the mechanism of action of iloperidone: reducing extrapyramidal symptoms (2013) (22)
- Nuevas guías para el uso de la polifarmacia antipsicótica (2013) (21)
- Sex and psychopharmacology: is natural estrogen a psychotropic drug in women? (2001) (21)
- Optimizing Outcomes in Schizophrenia: Long-acting Depots and Long-term Treatment (2012) (21)
- Analysis of the Rate of Improvement of Specific Psychic and Somatic Symptoms of General Anxiety Disorder During Long-Term Treatment with Venlafaxine ER (2007) (21)
- Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): modifying serotonin’s downstream effects on glutamate and GABA (gamma amino butyric acid) release (2015) (21)
- Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): actions at serotonin receptors may enhance downstream release of four pro-cognitive neurotransmitters (2015) (21)
- Mechanism of action of vesicular monoamine transporter 2 (VMAT2) inhibitors in tardive dyskinesia: reducing dopamine leads to less “go” and more “stop” from the motor striatum for robust therapeutic effects (2017) (21)
- Combining antidepressant therapies from the initiation of treatment: a paradigm shift for major depression. (2009) (21)
- Mechanism of action of stimulants in attention-deficit/hyperactivity disorder. (2010) (21)
- Sleep electroencephalographic response to muscarinic and serotonin1A receptor probes in patients with major depression and in normal controls (1998) (21)
- The relationship between hospital readmissions of medicare beneficiaries with chronic illnesses and home care nursing interventions. (1996) (20)
- Personalized Medicine, Pharmacogenomics, and the Practice of Psychiatry: On the Threshold of Predictive Therapeutics in Psychopharmacology? (2008) (20)
- Deconstructing psychiatric disorders, part 2: An emerging, neurobiologically based therapeutic strategy for the modern psychopharmacologist. (2003) (20)
- Play it Again: The Master Psychopharmacology Program as an Example of Interval Learning in Bite-Sized Portions (2010) (20)
- Dazzled by the dominions of dopamine: clinical roles of D3, D2, and D1 receptors (2017) (20)
- Serotonin neuroscience discoveries usher in a new era of novel drug therapies for psychiatry. (1992) (19)
- Brain fumes: yes, we have NO brain gas. (1998) (19)
- the dopamine hypothesis of schizophrenia (1976) (19)
- Antipsychotics and Mood Stabilizers. Stahl's Essential Psychopharmacology 3rd Ed (2008) (19)
- Brainstorms: symptoms and circuits, part 2: anxiety disorders. (2003) (19)
- Chronic administration of a selective dopamine D-2 agonist: factors determining behavioral tolerance and sensitization (2004) (19)
- Novel Therapeutics for Schizophrenia: Targeting Glycine Modulation of NMDA Glutamate Receptors (2007) (19)
- Independent actions on fear circuits may lead to therapeutic synergy for anxiety when combining serotonergic and GABAergic agents. (2002) (19)
- What makes an antipsychotic atypical? (1998) (19)
- Brain tonics for brain sprouts: how neurotrophic factors fertilize neurons. (1998) (19)
- Symptoms and circuits, part 1: major depressive disorder. (2003) (18)
- Psychopharmacology of anticonvulsants: do all anticonvulsants have the same mechanism of action? (2004) (18)
- Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies (2019) (18)
- Classifying psychotropic drugs by mode of action and not by target disorder (2013) (18)
- Serotonergic mechanisms and the new antidepressants (1993) (18)
- Do Dopamine Partial Agonists Have Partial Efficacy as Antipsychotics? (2008) (18)
- Pharmacotherapy of cognitive deficits in schizophrenia (2013) (17)
- Neuronal traffic signals in tardive dyskinesia: not enough “stop” in the motor striatum (2017) (17)
- Depression and Bipolar Disorder. Stahl's Essential Psychopharmacology (2008) (17)
- 5HT2 receptor changes in rat cortex and platelets following chronic ritanserin and clorgyline administration. (1990) (17)
- Mechanism of action of ketamine (2013) (17)
- Why drugs and hormones may interact in psychiatric disorders. (2001) (17)
- Evidence-based psychopharmacology (2005) (17)
- The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication. (2004) (17)
- Hallucinogenic drugs are partial agonists of the human platelet shape change response: A physiological model of the 5-HT2 receptor (1989) (16)
- Cholinergic and dopaminergic mechanisms in Tourette syndrome. (1982) (16)
- Brain computerized tomography in subtypes of severe chronic schizophrenia (1988) (16)
- Ziprasidone Hydrocloride: What Role in the Management of Schizophrenia? (2011) (16)
- Downregulation of serotonin receptor subtypes by nortriptyline and adinazolam in major depressive disorder: neuroendocrine and platelet markers. (1993) (15)
- Mechanism of action of dextromethorphan/quinidine: comparison with ketamine (2013) (15)
- "Hit-and-Run" actions at dopamine receptors, part 2: Illustrating fast dissociation from dopamine receptors that typifies atypical antipsychotics. (2001) (15)
- The Genetics of Schizophrenia Converge Upon the NMDA Glutamate Receptor (2007) (15)
- Clozapine: Is Now the Time for More Clinicians to Adopt This Orphan? (2014) (15)
- Efficacy of iloperidone in the short‐term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo‐ and active‐controlled trials (2012) (14)
- Sex therapy in psychiatric treatment has a new partner: reproductive hormones. (1997) (14)
- Deconstructing psychiatric disorders, Part 1. Genotypes, symptom phenotypes, and endophenotypes. (2003) (14)
- Functional psychopharmacology is the way to go in pharmacotherapy for psychiatric disorders (2010) (14)
- Natural estrogen as an antidepressant for women. (2001) (14)
- Antiparkinsonian activity of single oral dose of PHNO (1987) (14)
- The ups and downs of novel antiemetic drugs, part 1: substance P, 5-HT, and the neuropharmacology of vomiting. (2003) (14)
- Psychiatric Stress Testing: Novel Strategy for Translational Psychopharmacology (2010) (14)
- Prescriber's Guide (2020) (14)
- The study of olanzapine plus fluoxetine in treatment-resistant major depressive disorder without psychotic features (2000) (14)
- Comparing pharmacologic mechanism of action for the vesicular monoamine transporter 2 (VMAT2) inhibitors valbenazine and deutetrabenazine in treating tardive dyskinesia: does one have advantages over the other? (2018) (13)
- How to dose a psychotropic drug: beyond therapeutic drug monitoring to genotyping the patient (2010) (13)
- Psychopharmacology of wakefulness: pathways and neurotransmitters. (2002) (13)
- Estrogen makes the brain a sex organ. (1997) (13)
- Excitotoxicity and neuroprotection. (1997) (13)
- Fooling Mother Nature: Epigenetics and Novel Treatments for Psychiatric Disorders (2010) (13)
- Imaging neurotransmitters and their receptors in living human brain by positron emission tomography (1986) (13)
- Vasomotor symptoms and depression in women, part I. Role of vasomotor symptoms in signaling the onset or relapse of a major depressive episode. (2009) (13)
- Selective actions on sleep or anxiety by exploiting GABA-A/benzodiazepine receptor subtypes. (2002) (13)
- Neurochemistry of dopamine in Huntington's dementia and normal aging. (1986) (13)
- Expert Consensus on Screening and Assessment of Cognition in Psychiatry (2019) (13)
- Mechanism of action of tasimelteon in non-24 sleep-wake syndrome: treatment for a circadian rhythm disorder in blind patients (2014) (13)
- Mixed-up about how to diagnose and treat mixed features in major depressive episodes (2017) (13)
- Panic attacks and panic disorder: the great neurologic imposters. (1995) (12)
- The 7 habits of highly effective psychopharmacologists: overview. (2000) (12)
- Neuronal hyposensitivity to dopamine in the caudate nucleus depleted of biogenic amines by tegmental lesions. (1974) (12)
- Applying the Principles of Adult Learning to the Teaching of Psychopharmacology: Overview and Finding the Focus (2009) (12)
- The metabolic syndrome: psychopharmacologists should weigh the evidence for weighing the patient. (2002) (12)
- REL-1017 (Esmethadone) Increases Circulating BDNF Levels in Healthy Subjects of a Phase 1 Clinical Study (2021) (12)
- Regulation of neurotransmitter receptors by desipramine and other antidepressant drugs: the neurotransmitter receptor hypothesis of antidepressant action. (1984) (12)
- 'Best clinical practice': assessment of processes of care and of outcomes in the US Military Health Services System. (1998) (12)
- Deuterium Tetrabenazine for Tardive Dyskinesia. (2018) (12)
- Physostigmine in Tourette syndrome: evidence for cholinergic underactivity. (1981) (12)
- Epigenetics and methylomics in psychiatry. (2009) (12)
- Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson’s disease psychosis: an expert consensus (2018) (12)
- Next Generation Antidepressants (2010) (11)
- A successful antipsychotic combination trial. Quo Vadis? (2004) (11)
- Psicofarmacología esencial: bases neurocientíficas y aplicaciones clínicas (1998) (11)
- Antidepressants: the blue-chip psychotropic for the modern treatment of anxiety disorders. (1999) (11)
- Inverse agonists – What do they mean for psychiatry? (2017) (11)
- Finding what you are not looking for: Strategies for developing novel treatments in psychiatry (2011) (11)
- Ciprofloxacin and Clozapine: A Potentially Fatal but Underappreciated Interaction (2016) (11)
- Pharmacologic characteristics of Meige dystonia: differentiation from tardive dyskinesia. (1982) (11)
- Serotonin accumulation by skeletal muscle (1977) (11)
- Gut feelings about irritable bowel syndrome. (2001) (10)
- Affective symptoms in schizophrenia (2011) (10)
- When neurotrophic factors get on your nerves: therapy for neurodegenerative disorders. (1998) (10)
- Psychiatric Pharmacogenomics: How to Integrate into Clinical Practice (2017) (10)
- Teaching Psychopharmacology: What Works and What Doesn't (2008) (10)
- Olanzapine plus fluoxetine: Double-blind and open-label results in treatment-resistant major depressive disorder (1999) (10)
- Bottlenecks in the development of topical analgesics: molecule, formulation, dose-finding, and phase III design (2017) (10)
- Bromocriptine and lisuride in dystonias (1984) (10)
- Norepinephrine and dopamine regulate signals and noise in the prefrontal cortex. (2009) (9)
- The efficacy of piquindone, a new atypical neuroleptic, in the treatment of the positive and negative symptoms of schizophrenia. (1987) (9)
- Platelet alpha 2-adrenergic receptor sensitivity in major depressive disorder. (1983) (9)
- Biochemical pharmacology of serotonin receptor subtypes: hypotheses for clinical applications of selective serotonin ligands (1995) (9)
- Introduction: What makes an antipsychotic atypical? (1999) (9)
- Selectivity of SSRIs: individualising patient care through rational treatment choices (2004) (9)
- California State Hospital Violence Assessment and Treatment (Cal-VAT) guideline. (2014) (9)
- The 7 habits of highly effective psychopharmacologists, part 3: sharpen the saw with selective choices of continuing medical education programs. (2000) (9)
- Last episode psychosis (2009) (9)
- Comprar Antipsychotics and Mood Stabilizers. Stahl's Essential Psychopharmacology 3rd Ed | Stephen M. Stahl | 9780521714136 | Cambridge University Press (2008) (9)
- "Awakening" from schizophrenia: intramolecular polypharmacy and the atypical antipsychotics. (1997) (9)
- Relationship of cerebral ventricular size to alcoholics' performance on the Luria-Nebraska Neuropsychological Battery. (1981) (9)
- At long last, long-lasting psychiatric medications: an overview of controlled-release technologies. (2003) (9)
- Amyloid Cascade Hypothesis of Alzheimer's Disease (1997) (9)
- Serotonin: it's possible to have too much of a good thing. (1997) (9)
- Blue genes and the mechanism of action of antidepressants. (2000) (9)
- Novel agents in development for the treatment of depression (2013) (9)
- Neuroleptic effects in Tourette syndrome predict dopamine excess and acetylcholine deficiency. (1982) (9)
- Test of lepton universality with $$ {\Lambda}_b^0\to {pK}^{-}{\mathrm{\ell}}^{+}{\mathrm{\ell}}^{-} $$ decays (2019) (9)
- Comprar The Prescriber's Guide. Antidepressants. Stahl's Essential Psychopharmacology | Stephen M. Stahl | 9781107667969 | Cambridge University Press (2012) (9)
- Tardive dyskinesia: natural history studies assist the pursuit of preventive therapies (1986) (8)
- Forensic focused treatment planning: a new standard for forensic mental health systems (2015) (8)
- How and when to treat the most common adverse effects of antipsychotics: Expert review from research to clinical practice (2020) (8)
- Case report of four patients with Tourette syndrome treated with piquindone, a D2 receptor antagonist. (1986) (8)
- Independent regulation of beta 1- and beta 2-adrenoceptors. (1987) (8)
- Peptides and psychiatry, Part 3: substance P and serendipity: novel psychotropics are a possibility. (1999) (8)
- Mental illness may be damaging to your brain. (1997) (8)
- Serotonin depletion by fenfluramine in the carcinoid syndrome. (1982) (8)
- Molecular neurobiology for practicing psychiatrists, Part 5: How a leucine zipper can turn on genes: immediate-early genes activate late-gene expression in the brain. (2000) (7)
- Substance P and the neurokinins: novel peptide neurotransmitters in psychopharmacology. (1999) (7)
- Molecular neurobiology for practicing psychiatrists, part 2: how neurotransmitters activate second messenger systems. (1999) (7)
- Antipsychotics and mood stabilizers (2008) (7)
- Effect of long-term L-dopa administration on brain biogenic amines and behavior in the rat. (1973) (7)
- Comprar Stahl's Illustrated Attention Deficit Hyperactivity Disorder | Laurence Mignon | 9780521133159 | Cambridge University Press (2009) (7)
- Essential Evidence-Based Psychopharmacology (2012) (7)
- Alprazolam-XR: Dosage Considerations (1993) (7)
- PMH47 USE AND COST OF POLYPHARMACY IN SCHIZOPHRENIA: DATA FROM A RANDOMIZED, DOUBLE-BLIND STUDY OF RISPERIDONE AND QUETIAPINE (2005) (7)
- Fibromyalgia: the enigma and the stigma. (2001) (7)
- Here today and not gone tomorrow: the curse of chronic pain and other central sensitization syndromes. (2003) (7)
- The prescriber's guide to classic MAO-inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression. (2022) (7)
- A survey of national trends in psychiatric patients found incompetent to stand trial: reasons for the reinstitutionalization of people with serious mental illness in the United States (2020) (7)
- Should High Dose or Very Long-Term Antipsychotic Monotherapy Be Considered Before Antipsychotic Polypharmacy? (2013) (7)
- Integrating Psychotherapy and Psychopharmacology : A Handbook for Clinicians (2013) (6)
- Mirror, mirror on the wall, which enantiomer is fairest of them all? (2002) (6)
- The Vasopressin V 1 b Receptor Antagonist SSR 149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders : Results From 4 Randomized , Double-Blind , Placebo-Controlled Studies (2012) (6)
- Do some antidepressants have a faster onset of action than others (2001) (6)
- Dextromethorphan-quinidine–responsive pseudobulbar affect (PBA): psychopharmacological model for wide-ranging disorders of emotional expression? (2016) (6)
- Mergers and acquisitions among psychotropics: antidepressant takeover of anxiety may now be complete. (1999) (6)
- Can psychopharmacologic treatments that relieve symptoms also prevent disease progression? (2002) (6)
- New Medications for Neuropsychiatric Disorders. (2020) (6)
- Happy new year 2011 (2011) (6)
- Prophylactic antipsychotics: do they keep you from catching schizophrenia? (2004) (6)
- Evil, terrorism, and psychiatry (2017) (6)
- 5‐Hydroxytryptamine (5‐HT)‐induced shape change in human platelets determined by computerized data acquisition: correlation with [125I]‐iodo LSD binding at 5‐HT2 receptors (1991) (6)
- Drug information update. Unconventional treatment strategies for schizophrenia: polypharmacy and heroic dosing (2017) (6)
- Retraction of (1989) (6)
- Modulating the serotonin system in the treatment of major depressive disorder-ERRATUM (2015) (6)
- Applying the Principles of Adult Learning to the Teaching of Psychopharmacology: Storyboarding a Presentation and the Rule of Small Multiples (2009) (6)
- Nefazodone and the serotonin receptor modulators: a new member of a unique class of antidepressant agents (1995) (6)
- Case Studies: Stahl's Essential Psychopharmacology (2000) (6)
- Mechanism of action of suvorexant (2016) (6)
- Some relationships among assessments of depression. (2002) (6)
- Crisis in Army Psychopharmacology and Mental Health Care at Fort Hood (2009) (5)
- Mixed mood states: Baffled, bewildered, befuddled and bemused. (2019) (5)
- Optimizing Antidepressant Management of Depression: Current Status and Future Perspectives (2010) (5)
- Is impulsive violence an addiction? The Habit Hypothesis (2015) (5)
- Placebo response rate is ruining drug development in psychiatry: why is this happening and what can we do about it? (2019) (5)
- Illustrating the circuits of sexual desire. (2010) (5)
- Mechanism of action of alpha 2A-adrenergic agonists in attention-deficit/hyperactivity disorder with or without oppositional symptoms. (2010) (5)
- Dementia-related psychosis and the potential role for pimavanserin (2020) (5)
- Physostigmine in Gilles de la Tourette's syndrome. (1980) (5)
- Precision and personalized assessment, diagnosis and treatment in psychiatry (2020) (5)
- Therapeutic efficacy of a novel transdermal delivery system for (+)-PHNO in parkinsonian squirrel monkeys. (1989) (5)
- Treatment of Tourette's syndrome with RO22-1319, a D-2-receptor antagonist. (1984) (5)
- Pharmacological Comparative Characterization of REL-1017 (Esmethadone-HCl) and Other NMDAR Channel Blockers in Human Heterodimeric N-Methyl-D-Aspartate Receptors (2022) (5)
- Muscarinic acetylcholine receptors for psychotic disorders: bench-side to clinic. (2022) (5)
- Molecular neurobiology for practicing psychiatrists, Part 1: overview of gene activation by neurotransmitters. (1999) (5)
- Stahl's Illustrated Attention Deficit Hyperactivity Disorder (2009) (5)
- Improvement of symptoms in Tourette syndrome by piquindone, a novel dopamine-2 receptor antagonist. (1986) (4)
- Efficacy of olanzapine, fluoxetine and combination therapy in treatment-resistant major depressive disorder without psychotic features (1998) (4)
- Stahl's Illustrated Sleep and Wake Disorders (2016) (4)
- New drug discovery in the postgenomic era: from genomics to proteomics. (2000) (4)
- The ups and downs of novel antiemetic drugs, part 2: an illustration. (2003) (4)
- The 7 habits of highly effective psychopharmacologists, part 2: begin with the end in mind. (2000) (4)
- Applying the Principles of Adult Learning to the Teaching of Psychopharmacology: Audience Response Systems (2009) (4)
- Mental energy: plausible neurological mechanisms and emerging research on the effects of natural dietary compounds (2019) (4)
- Recognition molecules are trailblazers for axon pathways. (1998) (4)
- Next generation antidepressants : moving beyond monoamines to discover novel treatment strategies for mood disorders (2010) (4)
- Psychopharmacology and ethnicity: A comparative study on Senegalese and Italian men (2020) (4)
- Serotonin and Love: Supporting Evidence From a Patient Suffering From Obsessive-Compulsive Disorder. (2017) (4)
- Behavioural effects of (+)-4-propyl-9-hydroxynaphthoxazine in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (1988) (4)
- New hope for Alzheimer’s dementia as prospects for disease modification fade: symptomatic treatments for agitation and psychosis (2018) (4)
- Kick-off editorial for 2014: Thanks to our reviewers (2014) (4)
- Reply to Folate Supplementation: Is It Safe and Effective? (2009) (4)
- Apoptosis: neuronal death by design. (1997) (4)
- Serotonin agonists and beta-adrenergic agonists as a treatment for depressive disorder: a direct clinical application. (1985) (4)
- The tyranny of the majority and the interchangeability of drugs (2013) (4)
- Molecular neurobiology for practicing psychiatrists, part 3: how second messengers "turn on" genes by activating protein kinases and transcription factors. (1999) (4)
- Antipsychotics: Treating Psychosis, Mania and Depression (2010) (4)
- Stahl's Illustrated Substance Use and Impulsive Disorders: Psychosocial Treatment for Substance Use Disorders (2012) (4)
- Retraction: CSF monoamine metabolites in movement disorders and normal aging. (1989) (4)
- Anxiety Disorders : A Guide for Integrating Psychopharmacology and Psychotherapy (2013) (4)
- Violence in Psychiatry (2016) (4)
- Optimizing Outcomes in Psychopharmacology Continuing Medical Education (CME): Measuring Learning and Attitudes That May Predict Knowledge Translation into Clinical Practice (2006) (4)
- Serotonin receptor-specific mediation of antidepressant treatment effects in depressed patients (1995) (3)
- Introduction Neuropharmacology of Movement Disorders (1986) (3)
- Getting stoned without inhaling: anandamide is the brain's natural marijuana. (1998) (3)
- Pharmacologic Treatment of Mixed States. (2020) (3)
- Early response to trazodone once-a-day in major depressive disorder: review of the clinical data and putative mechanism for faster onset of action (2021) (3)
- A Horse of a Different Color: How Formulation Influences Medication Effects (2012) (3)
- Stahl's Self-Assessment Examination in Psychiatry: Psychosis and Antipsychotics (2012) (3)
- Paying attention to your acetylcholine, Part 2: the function of nicotinic receptors. (2000) (3)
- Flibanserin – the female Viagra? (2017) (3)
- A strategy for measuring the therapeutic properties of new antiparkinsonian drugs, such as +PHNO, in patients with on-off fluctuations. (1989) (3)
- Economics of decriminalizing mental illness: when doing the right thing costs less (2020) (3)
- Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling (2022) (3)
- Nootropics (1993) (3)
- Essential CNS Drug Development: Contents (2012) (3)
- Clinical Management of Major Depressive Disorder (2009) (3)
- Stahl's Self-Assessment Examination in Psychiatry: Pain and the Treatment of Fibromyalgia and Functional Somatic Syndromes (2012) (3)
- Molecular neurobiology for practicing psychiatrists, part 4: transferring the message of chemical neurotransmission from presynaptic neurotransmitter to postsynaptic gene expression. (1999) (3)
- Using neuroscience for naming psychotropic drugs (2016) (3)
- Neuropsychiatric Consequences of COVID-19 Pandemic: A Synthetic Review from a Global Perspective (2022) (3)
- Comprar The Prescriber's Guide, Antidepressants | Stephen M. Stahl | 9780521743969 | Cambridge University Press (2009) (3)
- Paying attention to your acetylcholine, Part 1: structural organization of nicotinic receptors. (2000) (3)
- Comprar Psicofarmacología esencial de Stahl. Bases neurocientíficas y aplicaciones prácticas 4Ed | S. Stahl | 9788478855766 | Aula Médica (2014) (3)
- Comprar Psicofarmacología esencial de Stahl. Bases neurocientíficas y aplicaciones prácticas 4Ed | S. Stahl | 9788478855766 | Aula Médica (2014) (3)
- Comprar Psicofarmacología esencial de Stahl. Bases neurocientíficas y aplicaciones prácticas 4Ed | S. Stahl | 9788478855766 | Aula Médica (2014) (3)
- Comprar Psicofarmacología Esencial de Stahl. Depresión y Trastorno Bipolar. 3Ed | Stephen M. Stahl | 9788478855063 | Aula Médica (2010) (3)
- Psicofarmacología esencial de Stahl. Bases neurocientíficas y aplicaciones prácticas 4Ed (2014) (2)
- Psicofarmacología esencial de Stahl. Bases neurocientíficas y aplicaciones prácticas 4Ed (2014) (2)
- Psicofarmacología esencial de Stahl. Bases neurocientíficas y aplicaciones prácticas 4Ed (2014) (2)
- Novel challenges to psychiatry from a changing world (2020) (2)
- Best Practices in Medical Teaching (2011) (2)
- The Clinical Use of Antipsychotic Plasma Levels (2021) (2)
- Positive findings for negative symptoms of schizophrenia: no longer untreatable? (2006) (2)
- Esmethadone (REL-1017) Compares With NMDA Receptor Antagonists in FLIPR-Ca2+ Assay (2021) (2)
- Understanding Why: Drivers of Suicide Risk (2021) (2)
- Stahl's Illustrated Chronic Pain and Fibromyalgia (2009) (2)
- Healthcare Provider Perspectives on Bipolar I Disorder Screening and the Rapid Mood Screener (RMS), a Pragmatic, New Tool (2021) (2)
- The effects of perturbation of cerebral amine metabolism on operationally defined learning and memory processes of goldfish. (1974) (2)
- The Psychopharmacology of Hallucinations: Ironic Insights into Mechanisms of Action (2013) (2)
- Off-label prescribing: best practice or malpractice? (2013) (2)
- Does a "whiff" of mania in a major depressive episode shift treatment from a classical antidepressant to an atypical/second-generation antipsychotic? (2017) (2)
- Stahl's Illustrated Antipsychotics (2010) (2)
- Stahl's Illustrated Anxiety, Stress, and PTSD (2010) (2)
- Vasomotor symptoms and depression in women, part 2. Treatments that cause remission and prevent relapses of major depressive episodes overlap with treatments for vasomotor symptoms. (2009) (2)
- Why psychiatrists should not ignore pain in their patients—focus on fibromyalgia? (2009) (2)
- Nicotine Dependence and Its Treatment (2010) (2)
- Using Atypical Antipsychotics in Primary Care. (2002) (2)
- New discoveries in the development of antipsychotics with novel mechanisms of action: beyond the atypical antipsychotics with serotonin dopamine antagonism (2000) (2)
- Dextromethorphan/bupropion: a novel oral NMDA (N-methyl-d-aspartate) receptor antagonist with multimodal activity—Addendum (2019) (2)
- 388. Reproductive hormones as adjuncts to psychotropic medications (1996) (2)
- Panic Attacks and Panic Disorders: The Great Imitators (2005) (2)
- Stahl's Illustrated Violence: Neural Circuits, Genetics and Treatment (2014) (2)
- Overview of Trends in Modern Psychopharmacology (2007) (2)
- Psicofarmacología esencial de antipsicóticos y estabilizadores del estado de ánimo (2003) (2)
- Drug Combinations and Augmentation Strategies for Difficult Cases of Obsessive Compulsive Disorder (1998) (2)
- Structural imaging of schizophrenia: is the modern psychiatrist becoming a ‘disease scene investigator?’ (2012) (2)
- Novel and Investigational Drugs in Depression (2014) (2)
- The N-Methyl-D-Aspartate Receptor Blocker REL-1017 (Esmethadone) Reduces Calcium Influx Induced by Glutamate, Quinolinic Acid, and Gentamicin (2022) (2)
- SEROTONIN RECEPTOR DOWN REGULATION BY ANTIDEPRESSANTS: PLATELET AND NEUROENDOCRINE MARKERS IN HUMANS (1992) (2)
- Akathisia Variants and Tardive Dyskinesia-Reply (1986) (2)
- Esmethadone (REL-1017) Reduces Glutamate-Induced Currents in NMDA Receptors With the GluN2D Subunit (2021) (2)
- Commentary on the limitation of antidepressants in current use (2001) (1)
- The Role of Culture and Societal Factors (2021) (1)
- Comprar Case studies: sthal's essential psychopharmacology | S. Stahl | 9780521182089 | Cambridge University Press (2011) (1)
- 1053 – In Vitro Receptor-binding Profile Of Lurasidone And Other Commonly-used Antipsychotics (2013) (1)
- Disorders of Sleep, Wakefulness and their Treatment (2012) (1)
- Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson’s disease psychosis: an expert consensus (2019) (1)
- Remeron (mirtazapine): Designing Specific Serotonergic Actions (1997) (1)
- Inpatient Psychiatric Research (1988) (1)
- New Routes of Administration for Antiparkinsonian Therapy (1989) (1)
- On the effect of modulation of cerebral amine metabolism on the learning and memory of goldfish (Carassius auratus). (1971) (1)
- Developments in Antidepressants (2003) (1)
- Comprar Stahl's Illustrated Mood Stabilizers | Stephen M. Stahl | 9780521758499 | Cambridge University Press (2009) (1)
- Conditions of life and death of psychiatric patients in France during World War II: euthanasia or collateral casualties? (2017) (1)
- Inpatient clinical research: its importance in psychiatry and psychopharmacology. (1986) (1)
- Comprar The Prescriber's Guide, Antipsychotics and Mood Stabilizers | Stephen M. Stahl | 9780521759007 | Cambridge University Press (2009) (1)
- Preemptive analgesia: is pain less costly when you pre-pay for it? (2004) (1)
- Mechanism of action of voltage sensitive sodium channel modulators. (2004) (1)
- CNS Spectrums: a new publisher, a new editor-in-chief, and new vistas (2012) (1)
- Glutamate: The Universal Excitatory Neurotransmitter (1997) (1)
- The Cytochrome P450 System, Part 2: 3A3,4 (1997) (1)
- Attention Deficit Hyperactivity Disorders: Animal Models (2014) (1)
- 90-69 Meta-analysis of randomized, double-blind, placebo-controlled studies of mirtazapine vs amitriptyline (1997) (1)
- Pharmacology: policy implications of new psychiatric drugs. (1992) (1)
- Teaching Neurobiology in Psychiatry (2019) (1)
- Essential Pain Pharmacology: Acknowledgements (2012) (1)
- Developments in Psychopharmacology for Major Depressive Disorder (2012) (1)
- Reply to Polypharmacy in Schizophrenia: A Fuzzy Concept (2003) (1)
- Dr. Stahl Replies (2000) (1)
- CORRELATION BETWEEN INCREASES OF FOOD-INTAKE AND PLASMA ACTH LEVELS AFTER ADMINISTRATION OF 5-HT1A AGONISTS IN RATS (1987) (1)
- Psilocybin in Neuropsychiatry: a review of its pharmacology, safety and efficacy. (2022) (1)
- Use of Medications in Suicide Prevention (2021) (1)
- Youth and Adolescents (2021) (1)
- Introduction: optimizing wakefulness in patients with fatigue and executive dysfunction. (2003) (1)
- Neurochemistry of dopamine in Huntingtonʼs dementia and normal aging (1987) (1)
- Neuroscience-Based Nomenclature: Classifying Psychotropics by Mechanism of Action Rather Than Indication (2017) (1)
- Polypharmacy- Purpose, Benefits and Limitations. (2022) (1)
- Esmethadone (REL-1017) Restores NMDA Receptor 1 Subunit Expression in an In Vitro Model of Glutamatergic Excitotoxicity (2021) (1)
- Emerging drugs for the treatment of major depressive disorder (2022) (1)
- Benefits and Challenges of Integrated Treatment (2013) (1)
- Best Practices in Medical Teaching: Measuring outcomes and ensuring success (2011) (1)
- Drug combinations for bipolar spectrum disorders: evidence-based prescribing or prescribing-based evidence? (2004) (1)
- Antidepressant Combinations and Augmentation Strategies for Difficult Cases, Part 1: The Serotonin Strategy versus the Classic Strategies (1997) (1)
- Major Depressive Disorder : Understanding the Signi fi cance of Residual Symptoms and Balancing Ef fi cacy with Tolerability (2015) (1)
- Ziprasidone in the Treatment of Bipolar Disorder (2011) (1)
- Medicolegal Risk Management (2021) (1)
- Esmethadone (REL-1017) Shows Similar Effects to Ketamine in Manual Patch Clamp Studies (2021) (1)
- Chronic pain and fibromyalgia (2009) (1)
- Stahl's Illustrated Antidepressants (2006) (0)
- Essential Pain Pharmacology: Modafinil (2012) (0)
- CNS volume 13 issue 6 Cover and Back matter (2008) (0)
- Serotonin Pathways: Mediators of SSRI Side Effects (1997) (0)
- Essential Pain Pharmacology: Tramadol (2012) (0)
- Essential Pain Pharmacology: Nabumetone (2012) (0)
- Hypoactive Sexual Desire Disorder (2018) (0)
- Essential Pain Pharmacology: Flurbiprofen (2012) (0)
- Essential CNS Drug Development: Preface (2012) (0)
- Essential Pain Pharmacology: Verapamil (2012) (0)
- Essential Pain Pharmacology: Naratriptan (2012) (0)
- Meet Our Editors (2012) (0)
- Can CSF measures distinguish among schizophrenia, depression, movement disorders, and dementia? (1985) (0)
- Observation of the decay $$ {\Lambda}_{\mathrm{b}}^0 $$ → χc1pπ− (2021) (0)
- Essential Pain Pharmacology: Sumatriptan, Sumatriptan/Naproxen (2012) (0)
- Comprar Stahl Ilustrados. Dolor crónico y fibromialgia | Stephen M. Stahl | 9788478855339 | Aula Médica (2011) (0)
- Essential Pain Pharmacology: Magnesium (2012) (0)
- Comprar Stahl Ilustrados. Trastorno por déficit de atención e hiperactividad (TDAH) | Laurence Mignon | 9788478855247 | Aula Médica (2011) (0)
- Treatments for Alzheimer's Disease: Past, Present, and Future (1997) (0)
- Essential CNS Drug Development: Plate Section (2012) (0)
- P.3.d.009 In vitro receptor binding profile of lurasidone and other commonly-used antipsychotics (2012) (0)
- Best Practices in Medical Teaching: Progress check answer sheets (2011) (0)
- Treat the treatable: a comprehensive and optimistic approach to treating psychiatric violence (2015) (0)
- Essential Pain Pharmacology: N -acetylcysteine (NAC) (2012) (0)
- Translating from neuroscience to psychiatry (and back translating from psychiatry to neuroscience) (2013) (0)
- The Fundamentals of Brain Neurotransmission (2018) (0)
- Essential Pain Pharmacology: Clomipramine (2012) (0)
- Best Practices in Medical Teaching: Using interval learning in a comprehensive medical educational program (2011) (0)
- Essential Pain Pharmacology: Riboflavin (2012) (0)
- Stahl's Illustrated Substance Use and Impulsive Disorders: Marijuana (2012) (0)
- CNS volume 17 issue 1 Cover and Front matter (2012) (0)
- Essential Pain Pharmacology: Morphine (2012) (0)
- CNS volume 19 issue 1 Cover and Front matter (2014) (0)
- Essential Pain Pharmacology: Oxaprozin (2012) (0)
- Essential Pain Pharmacology: Pregabalin (2012) (0)
- Reply to Letter to the Editor “Polypharmacy of 2 Atypical Antipsychotics” (2000) (0)
- CNS volume 20 issue 1 Cover and Front matter (2015) (0)
- Essential Pain Pharmacology: Duloxetine (2012) (0)
- Molecular and Cellular Biology Research in Psychiatry (2002) (0)
- Best Practices in Medical Teaching: References (2011) (0)
- Essential Pain Pharmacology: Pentazocine (2012) (0)
- Essential Pain Pharmacology: Mexiletine (2012) (0)
- Essential Pain Pharmacology: Introduction (2012) (0)
- Essential Pain Pharmacology: Celecoxib (2012) (0)
- Zuranolone, a Positive Allosteric Modulator of the GABAA Receptor: Hypothesized Mechanism of Action in Major Depressive Disorder (2023) (0)
- Essential Pain Pharmacology: Coenzyme Q10 (2012) (0)
- Index by Drug Name (2020) (0)
- CNS volume 19 issue S1 Cover and Front matter (2014) (0)
- Stahl's Self-Assessment Examination in Psychiatry: Bipolar Disorder and Mood Stabilizers (2012) (0)
- Comprar Next Generation Antidepressants | Chad E. Beyer | 9780521760584 | Cambridge University Press (2010) (0)
- Comprar Stahl's Illustrated Chronic Pain and Fibromyalgia | Stephen M. Stahl | 9780521133227 | Cambridge University Press (2009) (0)
- Comprar Case Studies: Sthal's Essential Psychopharmacology, Vol. 2 | Stephen M. Stahl | 9781107607330 | Cambridge University Press (2016) (0)
- Stahl's Self-Assessment Examination in Psychiatry: Multiple Choice Questions for Clinicians (2016) (0)
- Stahl's Self-Assessment Examination in Psychiatry: Dementia and Its Treatment (2012) (0)
- Essential Pain Pharmacology: Ziconotide (2012) (0)
- Essential Pain Pharmacology: Levorphanol (2012) (0)
- Essential Pain Pharmacology: Tolmetin Sodium (2012) (0)
- CNS volume 21 issue 5 Cover and Front matter (2016) (0)
- CNS volume 14 issue 6 Cover and Front matter (2009) (0)
- Essential Pain Pharmacology: Methadone (2012) (0)
- Essential Pain Pharmacology: Baclofen (2012) (0)
- Chapter 1 History of CNS drug development (2012) (0)
- Essential Pain Pharmacology: Desipramine (2012) (0)
- Essential Pain Pharmacology: Carisoprodol (2012) (0)
- CSF monamine metabolites in movement disorders and normal aging. (1985) (0)
- Serotonin Pathways: Mediators of SSRI Therapeutic Actions (1996) (0)
- The Role of Serotonin in Psychiatric Disorders . Edited by S.-L. Brown and H. M. van Praag. (Pp. 365; illustrated; $39.95.) Brunner/Mazel: New York. 1991. (1992) (0)
- Essential Evidence-Based Psychopharmacology: Preface (2012) (0)
- Stahl's Self-Assessment Examination in Psychiatry: Unipolar Depression and Antidepressants (2012) (0)
- Polypharmacy in schizophrenia: A fuzzy concept. Author's reply (2003) (0)
- Essential Pain Pharmacology: Zonisamide (2012) (0)
- Essential Pain Pharmacology: Dantrolene (2012) (0)
- CNS volume 18 issue 3 Cover and Front matter (2013) (0)
- Best Practices in Medical Teaching: Applying the principles of adult education to the designing of medical presentations (2011) (0)
- Essential Pain Pharmacology: Lidocaine 5% (2012) (0)
- [Influence of the cerebral amine metabolism on the memory of gold fishes]. (1971) (0)
- Esmethadone (REL-1017) Antagonizes NMDA Receptors and Reduces Ca2+ Entry in Presence of Quinolinic Acid and Gentamicin (2021) (0)
- Stahl's Illustrated Substance Use and Impulsive Disorders: Disorders of Impulsivity and Compulsivity (2012) (0)
- CNS volume 18 issue 3 Cover and Front matter (2013) (0)
- Best Practices in Medical Teaching: Using audience learning psychology to advantage in designing and delivering medical presentations (2011) (0)
- Reply to Combination Therapy: Is Clinical Practice Leading the Way? (2003) (0)
- Essential Pain Pharmacology: Metaxalone (2012) (0)
- Kick-Off Editorial for 2017: CNS Spectrums Is on the Move (2017) (0)
- Essential Pain Pharmacology: Metanx (Folate, B6, B12 Vitamins Combination) (2012) (0)
- Essential Pain Pharmacology: Oxcarbazepine (2012) (0)
- Stahl's Illustrated Substance Use and Impulsive Disorders: Other Drugs of Abuse (2012) (0)
- The Cal-DSH diversion guidelines (2020) (0)
- Phenytoin in Bipolar Depression: An Old Chapter, but Not Yet Properly Evaluated (2019) (0)
- Psychopharmacology: Child and Adolescent (2015) (0)
- Essential Pain Pharmacology: Dextromethorphan (2012) (0)
- The 7 habits of highly effective psychopharmacologists, Part 4: developing and implementing the vision. (2000) (0)
- Stahl's Self-Assessment Examination in Psychiatry: Frontmatter (2012) (0)
- What is an animal model ? (2005) (0)
- Accidental Flibanserin Ingestion in Children Causing Acute Respiratory and Central Nervous System Depression: What Health Care Professionals Need to Know. (2022) (0)
- Stahl's Self-Assessment Examination in Psychiatry: Introduction/Preface (2012) (0)
- Essential Pain Pharmacology: Valproic Acid and Derivatives (DPX) (2012) (0)
- Essential Pain Pharmacology: Flunarizine (2012) (0)
- Biological Psychiatry and Psychopharmacology (2019) (0)
- CNS volume 19 issue 4 Cover and Front matter (2014) (0)
- Comprar Stahl's Essential Psychopharmacology | Stephen M. Stahl | 9780521673761 | Cambridge University Press (2008) (0)
- Essential Pain Pharmacology: Sulindac (2012) (0)
- Essential Pain Pharmacology: Hydromorphone (2012) (0)
- Screening for Bipolar I Disorder and the Rapid Mood Screener: Results of a Nationwide Health Care Provider Survey. (2023) (0)
- Essential Pain Pharmacology: Gabapentin (2012) (0)
- Corrigendum: Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: An expert consensus (CNS Spectrums (2018) 23:6 (402-413) DOI: 10.1017/S1092852918001359) (2019) (0)
- Stahl's Self-Assessment Examination in Psychiatry: CME Information (2012) (0)
- Stahl's Illustrated Substance Use and Impulsive Disorders: The Neurobiology of Reward and Drug Addiction (2012) (0)
- The Cytochrome P450 System, Part 1: 1A2 and 2D6 (1997) (0)
- Reply to: Case studies are not sufficient (2011) (0)
- Do We Need a New Nomenclature for Atypical Antipsychotics? A Survey of Health Care Professionals and Patients. (2023) (0)
- Essential Pain Pharmacology: Memantine (2012) (0)
- CNS volume 18 issue 6 Cover and Front matter (2013) (0)
- Kick-Off Editorial for 2016: Thanks to Our Reviewers (2016) (0)
- Essential Pain Pharmacology: Fluvoxamine (2012) (0)
- Essential Pain Pharmacology: Lamotrigine (2012) (0)
- Essential Pain Pharmacology: Capsaicin 8% Topical Patch (2012) (0)
- Essential Pain Pharmacology: Carbamazepine (2012) (0)
- CNS volume 20 issue 6 Cover and Front matter (2015) (0)
- Stahl's Illustrated Substance Use and Impulsive Disorders: Nicotine (2012) (0)
- Psicofarmacología esencial de Stahl. Guía del prescriptor 5ed (2016) (0)
- Comprar The Prescriber's Guide Online bundle | Stephen Stahl | 9780521149686 | Cambridge University Press (2010) (0)
- Essential Pain Pharmacology: Doxepin (2012) (0)
- Stahl's Self-Assessment Examination in Psychiatry: CME: Posttest and Certificate (2012) (0)
- Essential Pain Pharmacology: Methocarbamol (2012) (0)
- Essential Pain Pharmacology: Fenoprofen (2012) (0)
- Comprar Stahl's Illustrated Anxiety, Stress, and PTSD | Stephen M. Stahl | 9780521153997 | Cambridge University Press (2010) (0)
- Progress check answer sheets (2011) (0)
- Breaking down long-term chronic aggression within a forensic hospital system (2020) (0)
- Stahl's Illustrated Substance Use and Impulsive Disorders: Abbreviations (2012) (0)
- Translating Science into Action (2021) (0)
- depression: studies of DISEASE J neurotransmitter receptor lead the search for biochemical lesions and new drug therapies (1986) (0)
- Stahl's Illustrated Substance Use and Impulsive Disorders: CME: Posttest and Certificate (2012) (0)
- Essential Pain Pharmacology: Ergocalciferol, Cholecalciferol (Vitamin D) (2012) (0)
- Essential Pain Pharmacology: Choline Magnesium Trisalicylate (2012) (0)
- Essential Pain Pharmacology: Orphenadrine (2012) (0)
- Psicofarmacología esencial de Stahl. Guía del prescriptor 5ed (2016) (0)
- Psicofarmacología esencial de Stahl. Guía del prescriptor 5ed (2016) (0)
- CNS volume 20 issue 5 Cover and Front matter (2015) (0)
- New Developments in the Treatment of Epilepsy (2001) (0)
- EXPERT PANEL SUPPLEMENT CLINICAL MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (2009) (0)
- Book reviews (2003) (0)
- Essential Pain Pharmacology: Ketorolac (2012) (0)
- Best practice in medical teaching (2011) (0)
- Essential Pain Pharmacology: Ibuprofen (2012) (0)
- Agonist-Induced Down-Regulation of β1-Adrenergic Receptors: Possible Biochemical Rationale for Novel Antidepressants (1989) (0)
- Essential Pain Pharmacology: Oxycodone (2012) (0)
- Comparison of Spontaneous and Drug-Induced Movement Disorders (1986) (0)
- Essential Pain Pharmacology: Dihydroergotamine (DHE) (2012) (0)
- Essential Pain Pharmacology: List of Icons (2012) (0)
- Reply (2011) (0)
- Essential Pain Pharmacology: Escitalopram (2012) (0)
- The Efficacy of Lumateperone in Patients With Bipolar Depression With Mixed Features. (2023) (0)
- BRIEF REPORTS The Efficacy of Piquindone, a New Atypical Neuroleptic, in the Treatment of the Positive and Negative Symptoms of Schizophrenia (1987) (0)
- Essential Pain Pharmacology: Piroxicam (2012) (0)
- Essential Pain Pharmacology: Clonazepam (2012) (0)
- Essential Pain Pharmacology: Amitriptyline (2012) (0)
- Essential Pain Pharmacology: Fentanyl (2012) (0)
- Brainstorms: Is Psychopharmacologic "Inoculation" Effective in Preventing Posttraumatic Stress Disorder? (2005) (0)
- P0228 - Negative symptoms and quality of life: A randomized, 196-week, double-blind study of ziprasidone versus haloperidol (2008) (0)
- Essential Pain Pharmacology: Mefenamic Acid (2012) (0)
- The third generation of therapeutic innovation and the future of psychopharmacology (2021) (0)
- Essential Pain Pharmacology: Cyclobenzaprine (2012) (0)
- Beyond the Second Messenger: How Molecular Events Mediate Receptor Downregulation (1996) (0)
- CNS volume 21 issue S1 Cover and Back matter (2016) (0)
- CPNP 2019 Annual Meeting Poster Abstracts (2019) (0)
- Essential Pain Pharmacology: Etodolac (2012) (0)
- CNS volume 19 issue 5 Cover and Front matter (2014) (0)
- Esmethadone-HCl (REL-1017): a promising rapid antidepressant. (2023) (0)
- Essential Pain Pharmacology: Tizanidine (2012) (0)
- CNS volume 19 issue 5 Cover and Front matter (2014) (0)
- The biochemistry of depression (1988) (0)
- Stahl's Illustrated Substance Use and Impulsive Disorders: Stimulants (2012) (0)
- IgFluorodeoxyglucose PET in Schizophrenia (2009) (0)
- Essential Pain Pharmacology: Oxymorphone (2012) (0)
- Independent regulation of Il- and J32-adrenoceptors (2006) (0)
- Stahl's Self-Assessment Examination in Psychiatry: Basic Neuroscience (2012) (0)
- Stahl's Illustrated Substance Use and Impulsive Disorders: Substance Use and Addiction: An Overview (2012) (0)
- Essential Pain Pharmacology: Tiagabine (2012) (0)
- Essential Pain Pharmacology: Desvenlafaxine (2012) (0)
- Cariprazine Has Unique Potent Binding for D 3 Receptors and Other Unique (2016) (0)
- Best Practices in Medical Teaching: Preface (2011) (0)
- Attention Deficit Hyperactivity Disorder (ADHD) and Its Treatment (2012) (0)
- Essential Pain Pharmacology: Ketoprofen (2012) (0)
- Stahl's Illustrated Substance Use and Impulsive Disorders: References (2012) (0)
- Essential Pain Pharmacology: Zolmitriptan (2012) (0)
- Essential Pain Pharmacology: Codeine Sulfate (2012) (0)
- CNS volume 18 issue s1 Cover and Front matter (2013) (0)
- Essential Pain Pharmacology: Pamidronate (2012) (0)
- CNS volume 17 issue s1 Cover and Front matter (2012) (0)
- Essential Pain Pharmacology: Alpha Lipoic Acid (ALA) (2012) (0)
- Essential Pain Pharmacology: Meclofenamate (2012) (0)
- Essential Pain Pharmacology: Fluoxetine (2012) (0)
- Essential Pain Pharmacology: Hydrocodone (2012) (0)
- Kick-Off Editorial for 2013: Thanks to Our Reviewers (2013) (0)
- A social history of serious mental illness (2020) (0)
- Essential Pain Pharmacology: Paroxetine (2012) (0)
- Comprar Best Practices In Medical Teaching | Stephen Stahl | 9780521151764 | Cambridge University Press (2011) (0)
- Pack Psicofarmacología Esencial de Stahl 10 Libros (2011) (0)
- Comprar Stahl Ilustrados. Estabilizadores del humor | Stephen M. Stahl | 9788478855346 | Aula Médica (2011) (0)
- Comprar Stahl: autoevaluación en psiquiatría | Stahl, S. | 9788478855681 | Aula Médica (2013) (0)
- Comprar Stahl: autoevaluación en psiquiatría | Stahl, S. | 9788478855681 | Aula Médica (2013) (0)
- Comprar Stahl: autoevaluación en psiquiatría | Stahl, S. | 9788478855681 | Aula Médica (2013) (0)
- Stahl: autoevaluación en psiquiatría (2013) (0)
- Stahl: autoevaluación en psiquiatría (2013) (0)
- Stahl: autoevaluación en psiquiatría (2013) (0)
- Comprar Pack Psiquiatría Aula Médica 2010 - 4 libros | Basant K. Puri | 000000PACK002 | Aula Médica (2010) (0)
- Pack Psiquiatría Aula Médica 2010 - 4 libros (2010) (0)
- Comprar Psicofarmacología esencial de Stahl. Guía del prescriptor 5ed | Stahl, S. | 9788478855919 | Aula Médica (2013) (0)
- Comprar Psicofarmacología esencial de Stahl. Guía del prescriptor 5ed | Stahl, S. | 9788478855919 | Aula Médica (2013) (0)
- Comprar Psicofarmacología esencial de Stahl. Guía del prescriptor 5ed | Stahl, S. | 9788478855919 | Aula Médica (2013) (0)
- Comprar Violencia. Circuitos Neuronales, Genética Y Tratamiento. Stahl Ilustrados | Debbi A. Morrissette | 9788478855872 | Aula Médica (2015) (0)
- Stahl: Psicofarmacología Esencial basada en la Evidencia (2013) (0)
- Essential Pain Pharmacology: Maprotiline (2012) (0)
- Stahl Ilustrados. Ansiedad, estrés y PTSD (2012) (0)
- Stahl Ilustrados. Ansiedad, estrés y PTSD (2012) (0)
- Stahl Ilustrados. Trastorno por déficit de atención e hiperactividad (TDAH) (2011) (0)
- Stahl Ilustrados. Ansiedad, estrés y PTSD (2012) (0)
- Comprar Psicofarmacología Esencial De Stahl. Bases Seudocientíficas Y Aplicaciones Prácticas 4ª Ed. (Edición UNED) | Stephen M. Stahl | 9788436264562 | Aula Médica (2016) (0)
- CNS volume 24 issue 5 Cover and Front matter (2019) (0)
- Comprar Psicofarmacología Esencial De Stahl. Guía Del Prescriptor 5ª Ed. | Stephen M. Stahl | 9788478855919 | Aula Médica (2010) (0)
- Comprar Stahl Ilustrados. Ansiedad, estrés y PTSD | Meghan M. Grady | 9788478855445 | Aula Médica (2012) (0)
- Comprar Stahl Ilustrados. Ansiedad, estrés y PTSD | Meghan M. Grady | 9788478855445 | Aula Médica (2012) (0)
- Kick-off editorial for 2015: thanks to our reviewers (2015) (0)
- NREM Sleep (0)
- The Public Health Model of Suicide Prevention (2021) (0)
- Antagonist treatment is just as effective as replacement therapy for opioid addiction but neither is used often enough (2018) (0)
- Essential Pain Pharmacology: Nalbuphine (2012) (0)
- Senile dementia — and where are we now?: Senile dementia of the alzheimer type edited by J. Traber and W. H. Gispen Springer-Verlag, 1985. DM 138 (xi + 376 pages) ISBN 3 540 15712 3 (1986) (0)
- Neuroprotection: Rescuing the Brain From Endogenous Assassins (1997) (0)
- Essential Pain Pharmacology: Acetaminophen/Paracetamol (2012) (0)
- Essential Pain Pharmacology: Methylphenidate (2012) (0)
- Essential Pain Pharmacology: Dexmedetomidine (2012) (0)
- Essential Pain Pharmacology: Lacosamide (2012) (0)
- Two Receptor Superfamilies Mediate Fast and Slow Neurotransmission (1996) (0)
- Mechanism of action of cariprazine BRAINSTORMS — Clinical Neuroscience Update (2016) (0)
- P.1.132 Meta-analysis of randomized, double-blind, placebo-controlled studies of mirtazapine vs amitriptyline (1997) (0)
- Essential Pain Pharmacology: Bromelain (2012) (0)
- Essential Pain Pharmacology: Nortriptyline (2012) (0)
- Essential Pain Pharmacology: Indomethacin (2012) (0)
- Essential Pain Pharmacology: Ketamine (2012) (0)
- Essential Pain Pharmacology: Tapentadol (2012) (0)
- Essential Pain Pharmacology: Diflunisal (2012) (0)
- Comprar Stahl's Illustrated Antipsychotics | Stephen Stahl | 9780521149051 | Cambridge University Press (2010) (0)
- Essential Pain Pharmacology: Milnacipran (2012) (0)
- Stahl's Self-Assessment Examination in Psychiatry (2019) (0)
- Sigma receptor system pharmacology: new tools to explore links with psychosis and novel antipsychotic drugs (1989) (0)
- Comprar Stahl's Essential Psychopharmacology Online | Stephen M. Stahl | 9780521746090 | Cambridge University Press (2009) (0)
- Issue: Selective norepinephrine reuptake inhibitors such as atomoxetine increase both dopamine and norepinephrine in frontal cortex and may thereby enhance cognitive functioning in attention-deficit/hyperactivity disorder. (2003) (0)
- Selecting an Antidepressant by Matching Patient Profiles With Antidepressant Profiles (1997) (0)
- CNS volume 18 issue 4 Cover and Front matter (2013) (0)
- Essential Pain Pharmacology: Sertraline (2012) (0)
- ANATOMICAL VERSUS CHEMICAL BASIS OF NEUROTRANSMISSION (0)
- Essential Pain Pharmacology: Citalopram (2012) (0)
- Essential Pain Pharmacology: Rizatriptan (2012) (0)
- Drug Combinations and Augmentation Strategies for Difficult Cases of Panic Disorder (1998) (0)
- Stahl's Illustrated Mood Stabilizers (2009) (0)
- CNS volume 19 issue 3 Cover and Front matter (2014) (0)
- Mixed-up about how to diagnose and treat mixed features in major depressive episodes – CORRIGENDUM (2018) (0)
- Anxiety Disorders: Evidence-Based Integrated Biopsychosocial Treatment (2017) (0)
- Essential Pain Pharmacology: Topiramate (2012) (0)
- Essential Pain Pharmacology: Propranolol (2012) (0)
- CNS volume 26 issue 4 Cover and Front matter (2021) (0)
- Essential Pain Pharmacology: Almotriptan (2012) (0)
- Mechanism of action of fl ibanserin , a multifunctional serotonin agonist and antagonist ( MSAA ) , in hypoactive sexual desire disorder (2015) (0)
- Zuclopenthixol and Zuclopenthixol Decanoate; Flupenthixol and Flupenthixol Decanoate (2021) (0)
- Stahl's Self-Assessment Examination in Psychiatry: Anxiety and Anxiolytics (2012) (0)
- Essential Pain Pharmacology: Venlafaxine (2012) (0)
- Antidepressant Combinations and Augmentation Strategies for Difficult Cases, Part 2: The Heroic Strategy (1997) (0)
- Substance Use Disorders (SUD) and Their Treatment (2012) (0)
- Comprar Stahl Ilustrados. Ansiedad, estrés y PTSD | Meghan M. Grady | 9788478855445 | Aula Médica (2012) (0)
- Essential Pain Pharmacology: Calcitonin (2012) (0)
- Essential Pain Pharmacology: Imipramine (2012) (0)
- Targeting serotonin receptor subtypes as a strategy for the discovery of novel treatments in psychiatry (1995) (0)
- Essential Pain Pharmacology: Cyproheptadine (2012) (0)
- Response to the Letter to the Editor “Psychiatry’s undeclared identity crisis in a changing world” by Richard Skaff (2021) (0)
- Essential Pain Pharmacology: Clonidine (2012) (0)
- CNS volume 17 issue 4 Cover and Front matter (2012) (0)
- CNS volume 20 issue S1 Cover and Front matter (2015) (0)
- Brainstorms: Symptoms and Circuits, Part 3: Schizophrenia (2004) (0)
- Essential Pain Pharmacology: Diazepam (2012) (0)
- CNS volume 20 issue 2 Cover and Front matter (2015) (0)
- Neurofarmacología Esencial de Stahl. Guía del prescriptor (2011) (0)
- Excitotoxicity: Too Much Glutamate May Be Hazardous to Your Health (1997) (0)
- Comprar Stahl's Illustrated Antidepressants | Stephen M. Stahl | 9780521758529 | Cambridge University Press (2009) (0)
- The effect of first- and second-generation antipsychotics on brain morphology in schizophrenia: A systematic review of longitudinal magnetic resonance studies with a randomized allocation to treatment arms (2022) (0)
- Essential Pain Pharmacology: List of abbreviations (2012) (0)
- CNS volume 20 issue 3 Cover and Front matter (2015) (0)
- Reply to Letter to the Editor “Gold Versus Silver: The Issue of Functional Versus Symptomatic Recovery in Depression” (2000) (0)
- CNS volume 17 issue 3 Cover and Front matter (2012) (0)
- Essential Pain Pharmacology: Meperidine/Pethidine (2012) (0)
- Iloperidone for the Treatment of Schizophrenia--Selected Posters (2008) (0)
- Essential Pain Pharmacology: Dronabinol (2012) (0)
- Stahl's Illustrated Substance Use and Impulsive Disorders: CME Information (2012) (0)
- Essential Pain Pharmacology: Pizotifen (2012) (0)
- CNS volume 21 issue 3 Cover and Front matter (2016) (0)
- Essential Pain Pharmacology: Omega-3 Fatty Acids (2012) (0)
- Comprar Stahl: Psicofarmacología Esencial basada en la Evidencia | Stephen Stahl | 9788478855742 | Aula Médica (2013) (0)
- Essential Pain Pharmacology: Butorphanol (2012) (0)
- Long-Term Actions of SSRIs (1996) (0)
- Essential Pain Pharmacology: Diclofenac (2012) (0)
- Essential Pain Pharmacology: Botulinum Toxin Type A (2012) (0)
- Essential Pain Pharmacology: Aspirin (2012) (0)
- Muscarinic Cholinergic Receptor Agonists and Antagonists (2015) (0)
- Comprar Depression and Bipolar Disorder. Stahl's Essential Psychopharmacology | Stephen M. Stahl | 9780521714129 | Cambridge University Press (2008) (0)
- Essential Pain Pharmacology: Eletriptan (2012) (0)
- Best Practices in Medical Teaching: Executing the principles of adult learning in medical presentations (2011) (0)
- Essential Pain Pharmacology: Salsalate (2012) (0)
- Essential Pain Pharmacology: Carnitine (2012) (0)
- Essential Pain Pharmacology: Palmitoylethanolamide (PEA) (2012) (0)
- Essential Pain Pharmacology: Frovatriptan (2012) (0)
- SYMPTOMATIC AND FUNCTIONAL RECOVERY INDEX FOR NEGATIVE SYMPTOMS IN A 40-WEEK RANDOMIZED, DOUBLE-BLIND STUDY OF ZIPRASIDONE VERSUS HALOPERIDOL FOLLOWED BY A 3-YEAR DOUBLE-BLIND EXTENSION TRIAL (2010) (0)
- Genetics and Epigenetics of Mental Illness: Implications for Diagnosis and Treatment (2014) (0)
- Comprar Pack Psicofarmacología Esencial de Stahl 10 Libros | Stephen M. Stahl | 000000PACK001 | Aula Médica (2011) (0)
- Essential Pain Pharmacology: Index by class (2012) (0)
- Balancing the pendulum: rethinking the role of institutionalization in the treatment of serious mental illness (2020) (0)
- Essential Pain Pharmacology: Buprenorphine (2012) (0)
- Controversies in treating bipolar depression (2013) (0)
This paper list is powered by the following services:
Other Resources About Stephen Stahl
What Schools Are Affiliated With Stephen Stahl?
Stephen Stahl is affiliated with the following schools:
